Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - coated tablets - 6.33 base milligrams

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - thiethylperazine maleate - suppositories - 6.5 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - thiethylperazine maleate - solution for injection - 6.5 mg/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - thiethylperazine maleate 6.5 mg/ml - solution for injection - 6.5 mg/ml - active: thiethylperazine maleate 6.5 mg/ml

United States - English - NLM (National Library of Medicine)

pharma romlev inc. - cefditoren pivoxil (unii: 78tha212dh) (cefditoren - unii:81qs09v3yw) - cefditoren 200 mg - cefditoren pivoxil is indicated for the treatment of mild to moderate infections in adults and adolescents (12 years of age or older) which are caused by susceptible strains of the designated microorganisms in the conditions listed below. acute bacterial exacerbation of chronic bronchitis caused by haemophilus influenzae (including ß-lactamase-producing strains), haemophilus parainfluenzae (including ß-lactamase producing strains), streptococcus pneumoniae (penicillin susceptible strains only), or moraxella catarrhalis (including ß-lactamase-producing strains). community-acquired pneumonia caused by haemophilus influenzae (including ß-lactamase-producing strains), haemophilus parainfluenzae (including ß-lactamase-producing strains), streptococcus pneumoniae (penicillin-susceptible strains only), or moraxella catarrhalis (including ß-lactamase producing strains). pharyngitis/tonsillitis caused by streptococcus pyogenes . note: cefditoren pivoxil is effective in the eradication of streptococcus pyoge

United States - English - NLM (National Library of Medicine)

vansen pharma inc. - cefditoren pivoxil (unii: 78tha212dh) (cefditoren - unii:81qs09v3yw) - cefditoren 200 mg - spectracef® (cefditoren pivoxil) is indicated for the treatment of mild to moderate infections in adults and adolescents (12 years of age or older) which are caused by susceptible strains of the designated microorganisms in the conditions listed below. acute bacterial exacerbation of chronic bronchitis caused by haemophilus influenzae (including ß-lactamase-producing strains), haemophilus parainfluenzae (including ß-lactamase producing strains), streptococcus pneumoniae (penicillin susceptible strains only), or moraxella catarrhalis (including ß-lactamase-producing strains). community-acquired pneumonia caused by haemophilus influenzae (including ß-lactamase-producing strains), haemophilus parainfluenzae (including ß-lactamase-producing strains), streptococcus pneumoniae (penicillin-susceptible strains only), or moraxella catarrhalis (including ß-lactamase producing strains). pharyngitis/tonsillitis caused by streptococcus pyogenes . note: spectracef® is effective in the eradication of streptococcu

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

meiji seika pharma co., ltd. - cefditoren pivoxil - white tablet, diameter: 8.1 mm, thickness: 4.5 mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

nihon generic co.,ltd - cefditoren pivoxil - white tablet , major axis: 12.4 mm , minor axis: 5.8 mm , thickness: 4.5 mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

meiji seika pharma co., ltd. - cefditoren pivoxil - white tablet, diameter: 8.1 mm, thickness: 4.5 mm

Kenya - English - Pharmacy and Poisons Board

laboratory & allied ltd p.o.box 42875, nairobi, kenya - cefditoren pivoxil - film-coated tablet - each film coated tablet contains cefditoren… - cefditoren